Present and potential perspectives for information on alcohol use in the EU

Similar documents
Perspectives for information on alcohol use in the EU

Overview of drug-induced deaths in Europe - What does the data tell us?

Manuel Cardoso RARHA Executive Coordinator Public Health MD Senior Advisor Deputy General-Director of SICAD - Portugal

Smokefree Policies in Europe: Are we there yet?

Underage drinking in Europe

WCPT COUNTRY PROFILE December 2017 HUNGARY

WCPT COUNTRY PROFILE December 2017 SWEDEN

WCPT COUNTRY PROFILE December 2017 SERBIA

Alcohol-related harm in Europe and the WHO policy response

ALCOHOL CONSUMPTION IN EUROPE; TRADITIONS, GENERATIONS, CULTURE AND POLICY

Where do EU Contries set the limit for low risk drinking.

Alcohol Prevention Day

Trends in injecting drug use in Europe

Cross Border Genetic Testing for Rare Diseases

Drinking guidelines used in the context of early identification and brief interventions in Europe: overview of RARHA survey results

Injecting trends in Austria including results of a systematic literature review on interventions aiming to influence the route of administration

PARALLELISM AND THE LEGITIMACY GAP 1. Appendix A. Country Information

CNAPA Meeting Luxembourg September 2016

Engagement in language assessment / Regions of Europe

Alcohol in Europe and Brief Intervention. Dr Lars Møller Programme Manager World Health Organization Regional Office for Europe

Low risk drinking guidelines in Europe: results from RARHA survey E. Scafato, Istituto Superiore di Sanità, Italy

Yersiniosis SURVEILLANCE REPORT. Annual Epidemiological Report for Key facts. Methods. Epidemiology

Alcohol related harms to children and youth and ways to address it Case of Finland

508 the number of suicide deaths in deaths per 100,000 people was the suicide rate in Suicide deaths in 2013 by gender

EMCDDA-update HIV/HCV among people who inject drugs: situation and response

European Collaboration on Dementia. Luxembourg, 13 December 2006

European Status report on Alcohol and Health

European status report on alcohol and health Leadership, awareness and commitment

What s s on the Menu in Europe? - overview and challenges in the first pan- European food consumption survey

Emerging Risks Mapping of Activities in Member States. 67th Advisory Forum meeting, Utrecht, The Netherlands, 6 February 2018

Cannabis policies & cannabis use

Project Meeting Prague

The cancer burden in the European Union and the European Region: the current situation and a way forward

Where we stand in EFORT

REPORT FROM THE COMMISSION TO THE EUROPEAN PARLIAMENT, THE COUNCIL, THE EUROPEAN ECONOMIC AND SOCIAL COMMITTEE AND THE COMMITTEE OF THE REGIONS

UK bowel cancer care outcomes: A comparison with Europe

New trends in harm reduction in Europe: progress made challenges ahead

Current levels and recent trends in health inequalities in the EU: Updates from the EU Report

E. Scafato, C. Gandin, L. Galluzzo, S. Ghirini

Summary. 10 The 2007 ESPAD Report

Overview of European Consumption Databases

Global Trade in Lightweight Coated Writing Paper TradeData International Pty Ltd ( Page 1 5/18/2015

The health economic landscape of cancer in Europe

Monthly measles and rubella monitoring report

Nutrient profiles for foods bearing claims

Media Release. Inaugural study reveals that more than one in four women in European and Central Asian prisons locked up for drug offences

TEDDY. Teddy Network of Excellence. Annagrazia ALTAVILLA. Ph.D. Sciences Ethics LL.M. Health Law. diterranée

The Identification of Food Safety Priorities using the Delphi Technique

Table 7.1 Summary information for lung cancer in Ireland,

The Risk of Alcohol in Europe. Bridging the Gap June 2004

EFSA s Concise European food consumption database. Davide Arcella Data Collection and Exposure Unit

European Community Pharmacy: a reference in Public Health

Summary. The 2007 ESPAD report Substance use among students in 35 countries

Q1 What age are you?

real-time AQ data 2007 and plans for 2008

Real Life, Real PD Survey

National Institute on Alcohol Abuse and Alcoholism. Environmental Approaches

Transmission, processing and publication of HBS 2015 data

THE CVD CHALLENGE IN NORTHERN IRELAND. Together we can save lives and reduce NHS pressures

Outcome of proficiency test on EIA serology

Trichinellosis SURVEILLANCE REPORT. Annual Epidemiological Report for Key facts. Methods

Post-test of the advertising campaign Help

LEBANON. WCPT COUNTRY PROFILE December 2018

Biology Report. Is there a relationship between Countries' Human Development Index (HDI) level and the incidence of tuberculosis?

Estimating Smoking Related Cause of Death: a Cohort Approach Based on Lung Cancer Mortality in six European Countries

Rheumatoid Arthritis Disease Burden and Access to Treatment

Note on the harmonisation of SILC and EHIS questions on health

European Association of Dental Public Health Prevention of Oral Cancer

PRESS RELEASE ISSUED BY THE STATE UNIVERSITY OF NEW YORK AT ALBANY

Cannabis Use among People Entering Drug Treatment in Europe: A Growing Phenomenon?

DENMARK. WCPT COUNTRY PROFILE December 2018

Table 6.1 Summary information for colorectal cancer in Ireland,

EUVAC.NET A surveillance network for vaccine-preventable diseases

Finnish international trade 2017 Figures and diagrams. Finnish Customs Statistics

GERMANY. WCPT COUNTRY PROFILE December 2018

Finnish international trade 2017 Figures and diagrams. Finnish Customs Statistics

Current dietary habits in Europe far from plant based eating

Risk perception and food safety: where do European consumers stand today?

Research paper: Legal treatment of the use of cannabis for medical purposes in the member states of the European Union

Burden and cost of alcohol, tobacco and illegal drugs globally and in Europe

D7.1 Report summarising results of survey of EU countries to identify volumes and trends in relation to the import and export of stem cells

Design and Analysis of a Cancer Prevention Trial: Plans and Results. Matthew Somerville 09 November 2009

D7.1 Report summarising results of survey of EU countries to identify volumes and trends in relation to the import and export of stem cells

This document is a preview generated by EVS

Table 9.1 Summary information for stomach cancer in Ireland,

Tramadol-related deaths

A report on the epidemiology of selected vaccine-preventable diseases in the European Region 30% 20% 10%

Identifying Europe s information needs for effective drug policy Lisbon, EMCCDA

Prevention of Oral Cancer Special Interest Working Group

EFSA s activities on data collection (Art. 33) and proposal for a new initiative (EUMENU) H. Deluyker Director

Inequalities in health: challenges and opportunities in Europe Dr Zsuzsanna Jakab WHO Regional Director for Europe

The Economics of Tobacco Control and Tobacco Taxation: Challenges & Opportunities for a Tobacco Free Turkey

11 Melanoma of the skin

Transcription:

EMCDDA Present and potential perspectives for information on alcohol use in the EU Julian Vicente Luxembourg 7-8 June 2016 CNAPA meeting

Topics in this presentation 1.- EMCDDA overview and its work on surveys 2.- ESPAD project and links with EMCDDA 2

1.- EMCDDA Decentralised EU agency Established in 1993 Operating since 1995 Reference point on drugs in the EU 3

Mandate Recast Regulation of December 2006: Provide the Community and EU Member States with factual, objective, reliable and comparable information at European level concerning drugs and drug addiction and their consequences illicit drugs polydrug use 4

Reitox: a unique data collection system Reitox National Drug Observatories in 28 EU Member States, Norway and Turkey + cooperation with - CC and PCC (IPA) - EU Neighbouring countries (ENP) 5

Reitox yearly data collection process Standard Tables FONTE database Structured Questionnaires Workbooks Process, analysis & outputs Press clippings EWS 6

European Drug Report (EDR) package 7

In this part of the presentation Focus on survey information collected by Member States and provided to EMCDDA Potentialities of cooperation with other partners (e.g. DG Sante) on information collection 8

Areas of work Drug situation Demand - Epidemiology ( key indicators established) Supply and market information (key indicators under preparation) New drugs and trends Responses Prevention, treatment, harm reduction and social reintegration Supply reduction activities Best practice Policies, laws and economic issues 9

Key Epidemiological Indicators Prevalence and patters of drug use* in the general population (GPS) Prevalence and patters of Problem Drug Use (PDU)/High Risk Drug Use (HRDU) Treatment Demand due to drug problems (TDI) Drug-related Deaths (DRD) Drug-related Infectious Diseases (DRID) (*) in fact in most cases substance use -at national level- 10

Prevalence and patterns of drug use among the general population This information is obtained through national representative probabilistic surveys of the general population (adults and school children) 11

Timeline: General (National) Population Surveys on drugs/substance use implemented - 1995 1996-2000 2001-2005 2006-2010 2011-2014 Denmark Germany Greece* Spain France Finland Sweden UK Estonia Netherlands Slovakia Norway Belgium* Czech Italy Ireland Latvia Lithuania Hungary Austria* Poland Portugal Bulgaria Cyprus Romania Croatia Slovenia Turkey Luxembourg only still missing 12

European Model Questionnaire (EMQ) Set of items on modular form to: - Create a specific questionnaire - Inclusion in an existing questionnaires Modules on: - socio-demographics - illicit drugs prevalence and patterns of use - alcohol use, tobacco, medicines - (polydrug use) - risk perception and policy opinions 13

Current module on alcohol - Limited set of questions on prevalence and patterns (frequencies and binge drinking) - Countries are actually collecting alcohol information (often more detailed than the EMQ) - But EMCDDA has collated only very limited information (LTP, LYP, LMP by gender and age) - Not proactive in national harmonization 14

EMCDDA tools for Key Indicators - Annual expert meetings (methodology and results) - Regular data collection at national level - Annual collation of information by EMCDDA through national Focal Points (REITOX) 15

Last month prevalence of alcohol use young adults (15-34) ALL 100 90 80 70 60 50 40 30 20 10 0 16

Last month prevalence of alcohol use young adults (15-34) males (%) 100 90 80 70 60 50 40 30 20 10 0 17

Last month prevalence of alcohol use young adults (15-34) females (%) 100 90 80 70 60 50 40 30 20 10 0 18

Perspectives - Possible adoption of a new module on alcohol use based in RARHA questionnaire - More proactive role of EMCDDA in implementation of this module in national surveys - More proactive role in collation of the information at EU level (resources? mandate?) 19

2.- ESPAD project European School survey Project on Alcohol and other Drugs

- About 40 European countries and more than 110000 students in 2011 - It is maintained by a network of researchers in increasing cooperation with EMCDDA (role in coordination since 2015) - EMCDDA will support the next wave of data collection but additional funding will be needed for long term continuity 21

Why school surveys? - Cost effective - Relatively easy to conduct - Reach a large number of students in one setting - Relatively easy to standardise - Sampling relatively easy - High response rate among students - High validity, i.e. more honest answers than in other surveys 22

ESPAD data collections 26 countries in 1995 30 countries in 1999 35 countries in 2003 35 countries in 2007 (plus 5 in 2008) 39 countries in 2011 2015 work in progress 23

Purpose 1 (2) - Get access to comparable data on substance use among European students - Include as many European countries as possible - Monitor trends in»single countries»groups of countries»europe www.espad.org 24

Purpose 2 (2) - Serve as an incitement for alcohol and drug prevention among youth - Provide data that can be used as a part of the evaluation of» EU Drugs Strategy» EU Strategy on Alcohol» WHO Global Alcohol Strategy» National strategies www.espad.org 25

Strategy: standardisation - Target age group - Random sampling of classes - Master questionnaire - Survey leader protocol - Data collection procedure - Time of data collection - Common database - The ESPAD Handbook www.espad.org 26

100 All students frequency of having had five or more drinks on one occasion during the last 30 days (2011). - Binge drinking in last 30 days- 90 80 70 1 or 2 3 or more Number of occasions 60 50 40 30 20 10 0 27

Frequency of having had five or more drinks on one occasion during the last 30 days. Boys (2011). 100 90 80 1 or 2 3 or more Number of occasions 70 60 50 40 30 20 10 0 28

100 Frequency of having had five or more drinks on one occasion during the last 30 days. Girls (2011). 90 80 1 or 2 3 or more Number of occasions 70 60 50 40 30 20 10 0 29

100 90 80 70 Frequency of lifetime drunkenness. Boys (2011). 1 to 9 10 to 19 20 or more Number of occasions 60 50 40 30 20 10 0 30

Frequency of lifetime drunkenness. Girls (2011). 100 90 80 1 to 9 10 to 19 20 or more Number of occasions 70 60 50 40 30 20 10 0 31

Percentages 40 Proportion of male students having been drunk at the age of 13 or younger (2011). 35 30 25 20 15 10 5 0 32

Percentages 40 Proportion of female students having been drunk at the age of 13 or younger (2011). 35 30 25 20 15 10 5 0 33

Conclusions - EMCDDA has a solid structure for data collection and reporting in field of drugs. - With necessary arrangements it could contribute to collect alcohol data existing in national sources already reporting to EMCDDA - ESPAD is an European project on alcohol and other drugs in adolescents. EMCDDA is increasingly contributing to coordinate the project. - Though the primary interest of EMCDDA is drugs, ESPAD collects plenty of alcohol information 34

Thank you for your attention! julian.vicente@emcdda.europa.eu emcdda.europa.eu twitter.com/emcdda facebook.com/emcdda youtube.com/emcddatube flickr.com/photos/emcdda 35